MITORX THERAPEUTICS LIMITED
9400 GARSINGTON ROAD, OXFORD BUSINESS PARK, OXFORD  OX4 2HN- Active
- Private Limited Company
- Company No. 13237941
- Last Updated: 16 Apr 2024
Company Profile
MITORX THERAPEUTICS LIMITED was incorporated on Tuesday, March 2, 2021 as a Private Limited Company with registered address in OXFORD. MITORX THERAPEUTICS LIMITED has the status: Active and it's listed in the following category: Research and experimental development on biotechnology. This Private Limited Company has been operating for 3 years 6 months and 18 days.
Name | MITORX THERAPEUTICS LIMITED |
---|---|
Company number | 13237941 |
Company type | Private Limited Company |
Incorporation date | 02 Mar 2021 |
Status | Active |
Industry (SIC 2007) |
Address
Registered Address |
9400 GARSINGTON ROAD OXFORD BUSINESS PARK OXFORD OX4 2HN |
---|---|
Country Of Origin |
Map based on PostCode
Ownership Information
Individuals and organizations with significant control over the business either by owning at least 25% shares or by virtue of significant influence over the business.
Name | Nature of Control |
---|---|
Mr Jonathan David Rees Nationality: British |
Dates: Tuesday, March 2, 2021 - Tuesday, January 25, 2022
ownership of shares 50 to 75 percent
voting rights 50 to 75 percent
right to appoint and remove directors
|
Dr Norman Milne Law Nationality: British |
Dates: Tuesday, March 2, 2021 - Tuesday, January 25, 2022
ownership of shares 25 to 50 percent
voting rights 25 to 50 percent
|
Accounts and Confirmation
Type of accounts | TOTAL EXEMPTION FULL |
---|---|
End of financial Year | 31 March |
Next annual accounts due | 31 December 2024, (101 days left) |
Latest accounts | 31 March 2023 |
Next confirmation statement due | 15 March 2025 |
Last confirmation statement dated | 01 March 2024 |
Mortgages
Total of Mortgages | 1 |
---|---|
Mortgages Outstanding | 0 |
Mortgages Partially Satisfied | 1 |
Mortgages Satisfied/Paid | 0 |
Previous Names
Name | Change Date |
---|---|
MITORX THERAPEUTICS LIMITED | 02 Mar 2021 |
IFFLEY BIOTECH LTD | 22 Jul 2021 |